Article
Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
11 Jul 2022
Abstract excerpt
Chronic hepatitis B virus (HBV) infection remains a substantial public health burden worldwide. Alpha-interferon (IFNα) is one of the two currently approved therapies for chronic hepatitis B (CHB), to explore the mechanisms underlying IFNα treatment response, we investigated baseline and 24-week on-treatment intrahepatic gene expression profiles in 21 CHB patients by mRNA-seq. The data analyses demonstrated that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
